September 10, 2025Frontiers in MedicineOpen Access

Correction: Effect of remimazolam besylate versus midazolam on time to extubation in critically ill, mechanically ventilated patients: a randomized controlled trial

View Full Paper

Ask AI

Bookmark

Discussion

Randomized controlled trial compares sedative effects of remimazolam and midazolam in critically ill patients, indicating distinct extubation times.

Remimazolam besylate significantly reduced extubation time compared to midazolam in critically ill patients.
The main measure showed that patients sedated with remimazolam extubated faster, enhancing recovery.
This randomized controlled trial analyzed sedative effects in mechanically ventilated adults across multiple centers.
Findings may encourage clinical shifts in sedation practices for critical care, advocating for remimazolam use.

A 2025 study studied this question.

View Full Paper

Ask AI

Bookmark

Randomized controlled trial compares sedative effects of remimazolam and midazolam in critically ill patients, indicating distinct extubation times.